The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Alexander Reichart
No Relationships to Disclose
 
Ulli Simone Bankstahl
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Thomas Werner Kraus
No Relationships to Disclose
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Chiesi; GORE; Integra LifeSciences; MCI Group; MCI Group; Medupdate; Merck Serono; Sanofi; Sirtex Medical; Teva
Consulting or Advisory Role - Astellas Pharma; Novartis
Speakers' Bureau - Integra LifeSciences
Travel, Accommodations, Expenses - Astellas Pharma; Baxter; Chiesi; Falk Foundation; GORE; Integra LifeSciences; MCI Deutschland; Medupdate; Merck Serono; Novartis; Sanofi; Sirtex Medical; Teva
 
Jorg Trojan
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly Asia Ventures; Merck Serono; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Matthias Behrend
No Relationships to Disclose
 
Jochem Potenberg
No Relationships to Disclose
 
Nils Homann
No Relationships to Disclose
 
Marino Venerito
No Relationships to Disclose
 
Wolfram Bohle
No Relationships to Disclose
 
Michael Varvenne
No Relationships to Disclose
 
Claus Bolling
No Relationships to Disclose
 
Dirk M. Behringer
No Relationships to Disclose
 
Karsten Kratz-Alber
No Relationships to Disclose
 
Gabriele Margareta Siegler
Honoraria - Aurikamed; Deutsche Röntgengesellschaft; Eisai; Janssen-Cilag; medizinwelten services GmbH; Roche; Shire
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Janssen-Cilag
Research Funding - Beigene (Inst); Celgene (Inst); Isofol Medical (Inst); MOLOGEN (Inst); Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Lilly
 
Wael Hozaeel
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Celgene; Lilly; Merck Sharp & Dohme; Miami Cancer Institute; Roche; Servier; Shire
Speakers' Bureau - Lilly; MCI Breast Cancer Symposium; Merck Sharp & Dohme
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss